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Accepted 28 August 2016Hemorrhages, cerebrospinal fluid (CSF) fistula and infections are the most challenging post-operative complica-
tions in Neurosurgery [1–5]. Fibrin sealant agents have been developed with the aim to provide efficient hemo-
stasis and safe dural closure [3,6–14]. In this study we report our initial experience using TachoSil® (haemostatic
surgical patch; Nycomed, Linz, Austria) in achieving hemostasis and CSF leakage repair during cranio-cerebral
procedures [15–18]. We describe and show the unique features of this fibrin sealant, pioneered with stunning
success in many surgical procedures known to be at high risk of peri- and postoperative bleeding (i.e. nephrec-
tomies, pulmonary lobectomies, ballistic injuries, arthroplasties, coronary bypass graftings), but still not widely
exploited at its best in the field of Neurosurgery.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Dural repair remains a source of morbidity during and following
neurosurgery operations. Postoperative cerebrospinal fluid (CSF) leak-
age remains the most serious and life-threatening complication. Persis-
tent CSF leakage is a significant concern for surgeons, as this
complication has been associatedwith increased timeof hospitalization,
worse neurological outcome, and development of CSF fistule [1–5].
During tumor removal, ventricular cavities opening may occur; in
these cases, cerebrospinal fistula may become even more common [3,
6–14]. In particular, in cases of lesions involving the fourth ventricle,
the aim of the surgery is to cover the surgical bed and restore the roof
of the ventricle avoiding any potential compression. In this study, we
analyze our experience of using TachoSil® (haemostatic surgical
patch; Nycomed, Linz, Austria) in microneurosurgical procedures [15–
18]. In five cases we used TachoSil as dural sealing and as ventricular
wall restoring. It demonstrated to assure a safe and durable dural
sealing and to reconstruct the regular ventricular anatomy eliminating
the risky complication of ventricular occlusion.2. Material and methods
A study was carried out in the Department of Neurosurgery at the
University Hospital of Palermo upon approval of local institutional re-
view board. Beginning on January 1, 2015 we prospectively analyzed 5
surgeries performed by the senior author (DGI), who used TachoSil®.ntal Biomedicine and Clinical
ne” Universita' degli Studi di
a).
. This is an open access article underThe patient group included four women and one man; the mean age
was 53 years old (range 40–67). Indications for surgery included re-
moval of glial tumors in four cases and evacuation of intracranial hem-
orrhage in one case. The pterional approach was used most commonly
to remove the tumors and a suboccipital craniectomy was performed
in one patient affected by intracerebellar hemorrhage. During surgery
TachoSil® served different purposes including bed covering after
tumor resection, dural covering to ensure watertight closure and ven-
tricularwall restoring following ventricles opening in the surgical fields.
In 3 cases it was used to cover the frontal horn opening in the surgical
field and as dural sealing (Fig. 1). In these cases the yellow side of the
sponge was cut in the size of interest and applied with wet
bayonet along the surgical bed and above the frontal horn opening
(Fig. 2). In one case it was used only as dural sealing and in the remain-
ing fifth case it was used to reconstruct the roof of the fourth ventricle
after the evacuation of a massive intracerebellar hemorrhage.3. Results
Patients received postoperative care according to local neurosurgical
department protocol, including a postoperative CT scan after each crani-
otomyand a brainMRIwithin 3–4 days post tumor removal. Primary as-
sessment of the wound took place during the hospital stay as well as at
discharge or transfer to a rehabilitation unit. The last wound assessment
was performed at the Neurosurgical Department outpatient clinic with
a mean follow-up time of 6 months (range 3–10 months). None of the
patients developed postoperative hematoma after craniotomy or
liquoral collection. At primary assessment, all patients had had no
wound-related problems over the normal course of healing. No case
registered any liquor leak from the wound, and none of the patientsthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Intraoperative picture of the ventricular opening following brain tumor removal. The frontal horn opened into the surgical field and was covered with a slice of TachoSil patch.
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last follow-up, all patients experienced uneventful wound healing.4. Discussion
TachoSil® (haemostatic surgical patch; Nycomed, Linz, Austria) is a
fixed combination of a collagenmatrix coatedwith two coagulation fac-
tors such as fibrinogen and thrombin. TachoSil® is indicated in surgery
as supportive treatment for improvement of hemostasis, to promote tis-
sue sealing, and for suture support in vascular surgery [16–17].
TachoSil includes a white collagen sponge coated on one side, with
human fibrinogen, thrombin and riboflavin giving it a yellowish color.
The carrier of the substance is equine collagen,which is free of immuno-
genic epitopes. The yellow side of the TachoSil® fleece is the active part
and should be applied at the site of bleeding. TachoSil® has served as a
hemostat in procedures such as lung, kidney, spleen, or liver surgery
and, more recently, cardiovascular surgery [13–18]. Moreover, recently
it's has been used in neurosurgical procedures as sealant and hemostatic
agent [19–24].
In our Neurosurgical Center we use TachoSil® to provide fibrinogen
and thrombin locally at the site of the surgical bed and along dural de-
fects. Indeed, upon contact with fluid the clotting factors of TachoSil®
dissolve and form a fibrin network, which glues the collagen sponge
to the wound surface. Combining the clotting factors in a collagen
patch provides a high concentration of clotting factors at the site
where it is specifically needed. Despite it's recommended to use it
only as a hemostat, in our experience, TachoSil® served as an effective
sealant an adhesive. Our procedures showed that closing the duraldefect with TachoSil® is a technically simple, reliable and safe method
for patients. Moreover, we specifically documented an important
novel technical feature of TachoSil®, such as it's reconstructing effect
on the ventricular wall. Indeed, it demonstrated to be able to cover
the ventricular wall defect, closing the connectionwith the surgical cav-
ity and avoiding the risk of ventricular obstruction (Fig. 2).
The sealing features of TachoSil® in occluding the surgical opening
of the ventricular system has been documented in literature. Bock
et al. reported on a series of nine patientswho underwent gross total re-
section of a glioblastoma with further implantation of a cytostatic drug
wafer into the resection cavity [24]. Since usage of wafers is not recom-
mended in surgical opening of the ventricular system, the authors used
TachoSil to occlude the connection between the resection cavity and the
ventricle. Such a strategy proved to be safe and effective in long-term
MRI follow-up, with no registered complications.
In our experience, TachoSil® was well tolerated and no adverse
event was documented. Although the risk of severe immunologic reac-
tions to bovinematerial is low, TachoSil® has gradually replaced all bo-
vine material with material of human origin and has therefore
eliminated the associated risks of bovine material.
Drawback of TachoSil® application is its propensity to adhere to the
instrument; however, keeping the instrument wet and clean is useful in
avoiding this annoying tendency.Declaration of interest
The authors report no declarations of interest. No funds were re-
ceived in support of this work.
Fig. 2. Pre and post operative brain MRI showing the complete removal of the brain tumor. No liquoral or hemorrhagic collection is depicted.
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Our experience reinforces the thesis that the use of TachoSil in neu-
rosurgery is safe and effective. Its features as hemostat, adhesive and
sealant have been widely explored and appreciated. In our study we
pointed out on its reconstructive effect of the ventricular wall that
avoid communication between ventricles and surgical field without
causing any risk of liquoral obstruction. Thus it seems very convincing,
further studies with larger sample size are warranted to confirm the ef-
ficacy of TachoSil® patches for neurosurgical defects repair.
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